TradeWorx’s Madrigal Pharmaceuticals MDGL Stock Holding History

TradeWorx’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-486	Closed	-$85K	–	528
2013 Q2	$85K	Buy	+486	New	+$127K	0.04%	452

Other funds holding MDGL

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

TradeWorx's MDGL Position: Q3 2013 in Review

TradeWorx sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2013, closing a stake of 486 shares — an estimated $85K sold.

TradeWorx first reported a position in MDGL in Q2 2013 and held it in 1 quarter. The position peaked at $85K in Q2 2013. 84 funds tracked by Wall St. Rank hold MDGL as of Q3 2013.

TradeWorx reported no remaining Madrigal Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
TradeWorx sold 486 Madrigal Pharmaceuticals shares in Q3 2013, an estimated $85K.
TradeWorx first reported a position in Madrigal Pharmaceuticals in Q2 2013 and held it in 1 quarter.
TradeWorx's Madrigal Pharmaceuticals position peaked at $85K in Q2 2013.
84 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2013.

Based on TradeWorx's 13F filing for Q3 2013, filed 15 Nov 2013.